The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ESMO 2019 | Pancreatic cancer: moving forward

Name: Pancreatic cancer: moving forward
Uploaded: 2019-10-01T10:15:06Z
Duration: 1 min 48 s
Description: Michel Ducreux, MD, PhD, Gustave Roussy Institute, Villejuif, France, describes where we are at with the treatment of pancreatic cancer, and what the future holds at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Michel Ducreux • 1 Oct 2019

ESMO 2019

Gastrointestinal Cancer Pancreatic Cancer Folfirinox Gemcitabine Nab-paclitaxel

Michel Ducreux, MD, PhD, Gustave Roussy Institute, Villejuif, France, describes where we are at with the treatment of pancreatic cancer, and what the future holds at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.